Inflammation Research

, Volume 62, Issue 7, pp 653–657 | Cite as

Therapeutic potential of targeting inflammation

  • John A. Hamilton
Meeting Report

On 7–8 September 2012, at Bolton Landing, New York, the International Association of Inflammation Societies (IAIS) hosted a Translational Inflammation Summit which gathered a group of invited specialists from both academic institutions and the pharmaceutical industry for 2 days of intense presentations and discussions.

The goals of the Summit were: (1) to provide participants with the opportunity to present cutting-edge research in inflammatory processes and disorders and discuss means with which to translate these results into therapeutic benefit; and (2) to foster a cross-fertilization of ideas between scientists with different areas of specialty and interest in inflammation research.

The program included a combination of academic and industrial research talks (25 in total), with a focus on potential translational outcomes; there was also focus on unmet medical need in inflammatory/auto-immune disorders and on the future of inflammation research.

The list of 38 participants, with 17...


Rheumatoid Arthritis Periodontitis Inflammation Research Pulmonary Alveolar Proteinosis Industrial Researcher 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



I thank all presenters at the Summit for their contribution and to those who have contributed to the fruitful discussions. Elisabeth Peen is also thanked for comments on this report. The Summit was organized by Ian Ahnfelt-Rønne, Lisa Marshall, Kouji Matsushima, Elisabeth Peen and John Hamilton. We thank the following sponsors: Abbott, Abide Therapeutics, Biogen Idec, Celgene, Chugai Pharmaceutical Co., Ltd, GlaxoSmithKline, Janssen, Kyowa-Hakko-Kirin Co. Ltd, MedImmune, Novo Nordisk, Pfizer Inc., Roche Group and Regeneron Pharmaceuticals. A full report of the Summit and cited literature can be viewed on the IAIS website

Conflict of interest

The author declares no competing financial interests.

Supplementary material

11_2013_614_MOESM1_ESM.docx (21 kb)
Supplementary material 1 (DOCX 20 kb)

Copyright information

© Springer Basel 2013

Authors and Affiliations

  1. 1.University of Melbourne, Department of Medicine, The Royal Melbourne HospitalParkvilleAustralia

Personalised recommendations